Tempus AI, Inc. (NASDAQ:TEM) CFO James William Rogers Sells 23,030 Shares

Tempus AI, Inc. (NASDAQ:TEM) CFO James William Rogers sold 23,030 shares of the stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $45.97, for a total transaction of $1,058,689.10. Following the completion of the sale, the chief financial officer now directly owns 164,750 shares in the company, valued at $7,573,557.50. This trade represents a 12.26 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

James William Rogers also recently made the following trade(s):

• On Tuesday, February 18th, James William Rogers sold 31,780 shares of Tempus AI stock. The shares were sold at an average price of $82.33, for a total transaction of $2,616,447.40.
• On Wednesday, February 5th, James William Rogers sold 8,712 shares of Tempus AI stock. The shares were sold at an average price of $67.57, for a total transaction of $588,669.84.

Tempus AI Stock Performance

Shares of TEM traded up $2.29 during trading hours on Wednesday, reaching $48.03. 11,624,616 shares of the company traded hands, compared to its average volume of 5,018,008. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The business has a fifty day moving average price of $55.86 and a 200-day moving average price of $51.48. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $91.45.

Institutional Trading of Tempus AI

Large investors have recently added to or reduced their stakes in the company. Operose Advisors LLC purchased a new stake in Tempus AI in the fourth quarter valued at approximately $25,000. First Horizon Advisors Inc. purchased a new stake in shares of Tempus AI in the 3rd quarter valued at $30,000. Farther Finance Advisors LLC purchased a new stake in shares of Tempus AI in the 4th quarter valued at $34,000. Prestige Wealth Management Group LLC boosted its holdings in shares of Tempus AI by 910.4% in the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after acquiring an additional 965 shares during the last quarter. Finally, NewEdge Advisors LLC purchased a new stake in Tempus AI in the fourth quarter valued at $49,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on TEM shares. Guggenheim reiterated a “buy” rating on shares of Tempus AI in a report on Tuesday, February 25th. Morgan Stanley lifted their target price on Tempus AI from $50.00 to $60.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. Bank of America lifted their price objective on shares of Tempus AI from $54.00 to $60.00 and gave the stock a “neutral” rating in a research report on Monday, March 3rd. Needham & Company LLC lifted their price objective on shares of Tempus AI from $56.00 to $70.00 and gave the stock a “buy” rating in a research report on Tuesday, February 25th. Finally, Piper Sandler cut their price target on shares of Tempus AI from $70.00 to $55.00 and set a “neutral” rating on the stock in a report on Tuesday, March 4th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $61.18.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.